FNA - Iranian Health Minister Saeed Namaki announced that the country is now manufacturing nearly all its needs to medicine, noting that two thirds of raw materials are also produced inside Iran.

"97% of the country's needs to medicine is produced domestically and the remaining 3% imported drugs will also be produced in Iran in future by 1,200 knowledge-based companies," Namaki said in a meeting with his Indonesian counterpart Nila Djuwita Farid Moeloek in Tehran on Saturday.

He also added that 67% of the raw materials needed for the country's pharmaceutical industry are also produced in the country.

Elsewhere, Namaki underlined Iran's enthusiasm for using Indonesia's experience in management of natural disasters as well as treatment and pharmaceutical fields.

Iran has taken long strides in producing different types of drugs and medical equipment and exported them to many foreign states.

A recent report by the scientific and technological department of Iran's presidential office said that the country is able to produce 97% of its needs to drugs indigenously.

in July, Iranian Vice-President for Science and Technology Sorena Sattari unveiled 8 new drugs during his visit to knowledge-based companies in Alborz province near Tehran.

The newly-developed drugs included Micro-Peltamparazole, Tamsulosin hydrochloride, Naltrexone base, Citalyptin phosphate, Peo gliatzone and other medicine.

The drugs have applications in treatment of digestive diseases and intestinal insufficiency, and will also be exported to the regional states.